Sort
8,912 grants matching “sars cov 2”
RADx-Rad Discoveries & Data: Consortium Coordination Center Program Organization
$5,848,902Lucila Ohno-Machado · University Of California, San Diego · U24 · FY2022 · LM
Targeting druggable coronavirus proteins
$5,786,835Michael R. Farzan · Scripps Research Institute, The · U19 · FY2022 · AI
UCSF COVID-19 Immunophenotyping Clinical Study and Core Laboratories
$5,742,559David J Erle · University Of California, San Francisco · U19 · FY2020 · AI
Discovery of new antiviral methylase, protease, and helicase inhibitors of corona-, flavi-, and alphaviruses
$5,701,101Thomas Tuschl · Hackensack University Medical Center · U19 · FY2022 · AI
RADx-Rad Discoveries & Data: Consortium Coordination Center Program Organization
$5,687,219Lucila Ohno-Machado · Yale University · U24 · FY2023 · LM
RAPID ACCELERATION OF DIAGNOTICS (RADX) ADVANCED TECHNOLOGIES PLATFORM RAPID ACCELERATION OF DIAGNOTICS (RADX) ADVANCED TECHNOLOGIES PLATFORM PROJECT
$5,665,290James Lu · Helix · N01 · FY2021 · HL
REVERSE-Long COVID: A Multicenter Randomized, Placebo-Controlled Clinical Trial of Immunomodulation (with Baricitinib) for Long COVID Related ADRD
$5,665,215E Wesley Ely · Vanderbilt University Medical Center · R01 · FY2024 · AG
CoVPN 3004 - A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine LOC
$5,663,427Lawrence Corey · Fred Hutchinson Cancer Center · UM1 · FY2022 · AI
Structural biology core
$5,661,828David A Agard · University Of California, San Francisco · U19 · FY2022 · AI
Core C: Vaccine production and process development
$5,637,003Lauren Carter · University Of Washington · U19 · FY2024 · AI
Experimental and Computational Analysis of the Human Epidemiology and Response to SARS-CoV-2 (HEROS) Cohort
$5,634,911Donald Ym Leung · National Jewish Health · UM1 · FY2021 · AI
Pandemic Assistance Core
$5,598,964Catherine A Blish · Stanford University · U19 · FY2022 · AI
Clinical and biomarker studies in Alzheimer's disease and related disorders
$5,587,710Dimitrios Kapogiannis · National Institute On Aging · ZIA · FY2023 · AG
Animal Model Core
$5,580,377David S Perlin · Hackensack University Medical Center · U19 · FY2022 · AI
Neuropathogenesis of Retroviral Infections
$5,580,007Avindra Nath · National Institute Of Neurological Disorders And Stroke · ZIA · FY2021 · NS
Serological Science for COVID-19 SeroNet
$5,554,144Leonard Freedman · Leidos Biomedical Research, Inc. · N01 · FY2020 · CA
RAPID ACCELERATION OF DIAGNOSTICS (RADX) TECH PROJECT #6139: REVOGENE SARS-COV-2 ASSAY
$5,505,000Todd Woodrich · · N02 · FY2021 · HL
RADx-UP SAY YES COVID Test Study (S4)
$5,500,000Michael Cohen-Wolkowiez · Duke University · U24 · FY2021 · MD
Targeting Viral RNA Using a Sequence Programmable Small Molecule-Oligonucleotide Conjugate
$5,450,416Kevan M. Shokat · University Of California, San Francisco · U19 · FY2022 · AI
Implementation and Real-World Effectiveness of Monoclonal Antibodies to Treat High-Risk Outpatients with COVID-19
$5,449,454Ronald J Sokol · University Of Colorado Denver · UL1 · FY2021 · TR
Pharmacokinetics and Drug Metabolism
$5,444,464Xin Xu · National Center For Advancing Translational Sciences · ZIA · FY2023 · TR
Population-based survey of SARS-CoV-2 infection and immune response
$5,429,240Aaron Julius Siegler · Emory University · R01 · FY2020 · AI
Project 3 â Direct-Acting Antivirals against Paramyxoviruses
$5,393,007Benhur Lee · Emory University · U19 · FY2022 · AI
Convalescent Plasma to Limit Coronavirus Associated Complications: Randomized Blinded Phase 2 Study Comparing Efficacy and Safety of Anti-SARS-CoV-2 Plasma to Placebo in COVID-19 Hospitalized Patients
$5,391,810Ralph Lewis Sacco · University Of Miami School Of Medicine · UL1 · FY2020 · TR
Scanning Probe Microscopy for the Intramural Research Community
$5,358,669Emilios K Dimitriadis · National Institute Of Biomedical Imaging And Bioengineering · ZIC · FY2023 · EB